João R M Martins, Reinaldo P Furlanetto, Lhoyane M Oliveira, Aline Mendes, Carlo C Passerotti, Maria Izabel Chiamolera, Antonio J Rocha, Paulo G Manso, Helena B Nader, Carl P Dietrich, Rui M B Maciel
OBJECTIVE: Immunosuppressive treatment of Graves' opthalmopathy (GO) should be restricted to patients with active eye disease, but assessing disease activity is difficult. Several methods to evaluate GO activity have been introduced, but none of them is satisfactory. Glycosaminoglycans (GAGs) are complex polysaccharides that participate on the pathogenesis of GO and attempts to correlate its local increase to urinary GAGs (uGAGs) or serum hyaluronan (sHA) have been made, but the available techniques are labourious, time-consuming and difficult for routine use...
June 2004: Clinical Endocrinology